157 related articles for article (PubMed ID: 11585240)
1. Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population.
First MR
Transplantation; 2001 Sep; 72(6 Suppl):S20-4. PubMed ID: 11585240
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and consequences of arterial hypertension after renal transplantation.
Koomans HA; Ligtenberg G
Transplantation; 2001 Sep; 72(6 Suppl):S9-12. PubMed ID: 11585243
[TBL] [Abstract][Full Text] [Related]
3. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
Groetzner J; Meiser BM; Schirmer J; Koglin J; vScheidt W; Klauss V; Cremer P; Reichenspurner H; Reichart B
Transplant Proc; 2001; 33(1-2):1461-4. PubMed ID: 11267373
[No Abstract] [Full Text] [Related]
5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.
Rabkin JM; Rosen HR; Corless CL; Olyaei AJ
Transplant Proc; 2002 Aug; 34(5):1557-8. PubMed ID: 12176483
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
8. Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence.
First MR
Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi17-vi22. PubMed ID: 15575022
[TBL] [Abstract][Full Text] [Related]
9. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
Copley JB; Staffeld C; Lindberg J; Hansen A; Bailey C; Anand R; Van Veldhuisen P
Transplant Proc; 1998 Jun; 30(4):1254-6. PubMed ID: 9636510
[No Abstract] [Full Text] [Related]
11. Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?
Vanrenterghem YF
Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):669-74. PubMed ID: 10630811
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for and management of post-transplantation cardiovascular disease.
Fellström B
BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitors in renal transplantation: what is the best option?
Tanabe K
Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus based immunosuppression.
First MR
J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
[TBL] [Abstract][Full Text] [Related]
16. Use of tacrolimus in renal transplantation.
van Hooff JP; Christiaans MH
Transplant Proc; 1999 Dec; 31(8):3298-9. PubMed ID: 10616483
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus in transplant rejection.
Rath T
Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
[TBL] [Abstract][Full Text] [Related]
18. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
19. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results.
Chamienia A; Dębska-Ślizień A; Król E; Biedunkiewicz B; Rutkowski B
Transplant Proc; 2014 Oct; 46(8):2714-8. PubMed ID: 25380901
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]